Opportunity Information: Apply for RFA CA 09 023
Apply for RFA CA 09 023
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Minority Based Community Clinical Oncology Program (U10)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.399 Cancer Control.
- This funding opportunity was created on May 1, 2009 and posted on May 1, 2009.
- Applicants must submit their applications by Jul 8, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,300,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 7 candidate(s).
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Minority Based Community Clinical Oncology Program (Minority Based CCOP) grant opportunity, funded by the National Institutes of Health (NIH) through the National Cancer Institute (NCI), is designed to keep an established national program going that brings NCI-sponsored cancer clinical trials into community settings that serve large minority populations. The central aim is to expand and strengthen participation of minority patients in cancer prevention, cancer control, and cancer treatment trials by directly engaging practicing oncologists and community-based providers who already care for these populations. In practical terms, the program functions as a bridge between minority communities and the larger NCI clinical trials enterprise, so that new research findings, improved prevention approaches, and updated treatment strategies can move faster from research settings into everyday care in underserved communities.
The opportunity emphasizes building and supporting “Minority Based CCOP groups” as a national resource. These groups are expected to conduct research activities tied to NCI-sponsored trials and to increase access for minority patients who are eligible to enroll. A key feature is connectivity: awardees are linked to clinical trials available through cancer centers, major university centers, and community programs that are part of the NCI clinical trials network. By creating this linkage, the program is intended to reduce gaps in trial access, encourage equitable representation in research, and help ensure that advances in cancer prevention and treatment are tested in, and reach, the populations that often experience disproportionate cancer burden and barriers to specialty care.
This funding announcement uses a cooperative agreement mechanism (U10), meaning the NCI is not simply providing funds and stepping back; it signals substantial scientific or programmatic involvement from the federal side during the project. Cooperative agreements are commonly used when an agency expects to collaborate with recipients on trial operations, research priorities, performance expectations, data quality, and coordination across a larger network. In this case, the U10 mechanism aligns with the program’s role in integrating community-based oncology practices into a national trials infrastructure where coordination, standardization, and oversight are essential.
Administratively, this was a discretionary funding opportunity (Funding Opportunity Number RFA-CA-09-023) in the Health/Education activity categories, associated with CFDA 93.399 (Cancer Control). The opportunity anticipated making about 7 awards, with an estimated total funding level of $4.3 million, and it did not require cost sharing or matching. The announcement was posted May 1, 2009, with an original and current closing date of July 8, 2009, and it was archived on August 8, 2009.
Eligibility was broad and included many types of organizations that could plausibly support community-facing oncology research operations. Eligible applicants included nonprofit organizations (both with and without 501(c)(3) status), public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, federally recognized Native American tribal governments, and other tribal organizations. The eligibility language also explicitly recognized a range of mission-driven and minority-serving institutions and entities, including Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions. Taken together, that eligibility scope reflects the program’s underlying goal: to meet minority communities where care is actually delivered and to support a variety of organizational models capable of enrolling participants and running trials with appropriate oversight.
Overall, the Minority Based CCOP opportunity is best understood as an implementation-focused clinical research infrastructure award for community oncology settings that serve minority populations. It is intended to expand trial access and participation, improve the flow of evidence-based cancer interventions into routine practice in minority communities, and strengthen the national clinical trials system by making it more representative and more connected to real-world care environments. For full details, the complete announcement was hosted by NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-023.html
Minority Based Community Clinical Oncology Program (Minority Based CCOP) - FAQs
What is the Minority Based Community Clinical Oncology Program (Minority Based CCOP) grant?
The Minority Based CCOP is an NIH-funded grant opportunity through the National Cancer Institute (NCI) designed to continue an established national program that brings NCI-sponsored cancer clinical trials into community settings that serve large minority populations.
What is the main purpose of this funding opportunity?
The central purpose is to expand and strengthen participation of minority patients in NCI-sponsored cancer prevention, cancer control, and cancer treatment clinical trials by directly engaging practicing oncologists and community-based providers who already care for these populations.
How does the program help minority communities in practical terms?
The program functions as a bridge between minority communities and the broader NCI clinical trials enterprise, helping new research findings, improved prevention approaches, and updated treatment strategies move more quickly from research settings into everyday care in underserved communities.
What types of research activities are supported under Minority Based CCOP groups?
Minority Based CCOP groups are expected to conduct research activities tied to NCI-sponsored trials and to increase access for minority patients who are eligible to enroll in those trials.
What does it mean that the opportunity emphasizes building “Minority Based CCOP groups” as a national resource?
It means awardees are expected to operate as part of a coordinated national capability that supports NCI-sponsored clinical trials in community settings serving minority populations, helping expand equitable trial access and participation across the country.
How are awardees connected to available clinical trials?
A key feature is connectivity: awardees are linked to clinical trials available through cancer centers, major university centers, and community programs that are part of the NCI clinical trials network.
Why is connectivity to the NCI clinical trials network important in this program?
This linkage is intended to reduce gaps in trial access, encourage equitable representation in research, and help ensure that advances in cancer prevention and treatment are tested in, and reach, populations that often face disproportionate cancer burden and barriers to specialty care.
What funding mechanism is used for this opportunity?
This funding announcement uses a cooperative agreement mechanism (U10).
What does a cooperative agreement (U10) imply for applicants and awardees?
A U10 mechanism signals substantial scientific or programmatic involvement from NCI during the project. It is not simply funding with minimal oversight; it reflects an expectation of collaboration on areas such as trial operations, research priorities, performance expectations, data quality, and coordination across a larger network.
Why does the program use a cooperative agreement rather than a standard grant mechanism?
Because the program integrates community-based oncology practices into a national trials infrastructure where coordination, standardization, and oversight are essential, the cooperative agreement structure aligns with the need for close coordination between awardees and NCI.
What is the Funding Opportunity Number for this announcement?
The Funding Opportunity Number is RFA-CA-09-023.
Which federal agencies are associated with this opportunity?
The opportunity is funded by the National Institutes of Health (NIH) through the National Cancer Institute (NCI).
What activity categories are associated with this funding opportunity?
The announcement was listed under Health/Education activity categories.
What CFDA program is associated with this opportunity?
This opportunity is associated with CFDA 93.399 (Cancer Control).
How many awards were anticipated?
The opportunity anticipated making about 7 awards.
What was the estimated total funding level for the opportunity?
The estimated total funding level was $4.3 million.
Was cost sharing or matching required?
No. The announcement stated that cost sharing or matching was not required.
When was the announcement posted?
The announcement was posted on May 1, 2009.
What was the closing date for applications?
The original and current closing date was July 8, 2009.
Is this funding opportunity still open?
No. The opportunity was archived on August 8, 2009, and the listed closing date was July 8, 2009.
What types of organizations were eligible to apply?
Eligibility included nonprofit organizations (with or without 501(c)(3) status), public and state-controlled institutions of higher education, private institutions of higher education, for-profit organizations other than small businesses, federally recognized Native American tribal governments, and other tribal organizations.
Were minority-serving institutions and community organizations explicitly recognized in the eligibility language?
Yes. The eligibility language explicitly recognized entities such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), as well as faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions.
Why is the eligibility scope so broad?
The eligibility scope reflects the program goal of meeting minority communities where care is delivered and supporting a variety of organizational models capable of enrolling participants and running clinical trials with appropriate oversight.
What is the overall focus of the Minority Based CCOP opportunity?
It is an implementation-focused clinical research infrastructure award for community oncology settings that serve minority populations, intended to expand trial access and participation, improve the flow of evidence-based cancer interventions into routine practice in minority communities, and strengthen the national clinical trials system by making it more representative and connected to real-world care environments.
Where can the full funding announcement be found?
The complete announcement was hosted by NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-023.html
Browse more opportunities from the same category: Education Health
Next opportunity: Renewal of Centers of Biomedical Research Excellence (COBRE)P20
Previous opportunity: Water, Sanitation and Hygiene (WASH) Program in Ethiopia
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 09 023
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 09 023) also looked into and applied for these:
| Funding Opportunity |
|---|
| Renewal of Centers of Biomedical Research Excellence (COBRE)P20 Apply for PAR 09 180 Funding Number: PAR 09 180 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers P30 Apply for RFA RR 09 005 Funding Number: RFA RR 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Community Clinical Oncology Program (U10) Apply for RFA CA 09 022 Funding Number: RFA CA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technologies and Software to Support Integrative Cancer Biology Research (SBIR) R43/R44 Apply for PA 09 188 Funding Number: PA 09 188 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) R43/R44 Apply for PA 09 187 Funding Number: PA 09 187 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs (SBIR) R43/R44 Apply for PA 09 189 Funding Number: PA 09 189 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Integrating Translational Neuroscience and Adolescent Drug Abuse Treatment (R21) Apply for RFA DA 10 003 Funding Number: RFA DA 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaborations on HIV/AIDS and Drug Use (R01) Apply for RFA DA 10 008 Funding Number: RFA DA 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Centers of Cancer Nanotechnology Excellence (CCNEs)(U54) Apply for RFA CA 09 012 Funding Number: RFA CA 09 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,200,000 |
| Cancer Nanotechnology Platform Partnerships (U01) Apply for RFA CA 09 013 Funding Number: RFA CA 09 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $400,000 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R01) Apply for PA 09 197 Funding Number: PA 09 197 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R21) Apply for PA 09 198 Funding Number: PA 09 198 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R21) Apply for PA 09 200 Funding Number: PA 09 200 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R01) Apply for PA 09 199 Funding Number: PA 09 199 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The National Drug Abuse Treatment Clinical Trials Network (U10) Apply for RFA DA 10 009 Funding Number: RFA DA 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Bioenergetics, Fatigability, and Activity Limitations in Aging (R21) Apply for PA 09 191 Funding Number: PA 09 191 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Bioenergetics, Fatigability, and Activity Limitations in Aging (R01) Apply for PA 09 190 Funding Number: PA 09 190 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Apply for PAR 09 162 Funding Number: PAR 09 162 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20) Apply for PAR 09 201 Funding Number: PAR 09 201 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) Apply for PA 09 208 Funding Number: PA 09 208 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 09 023", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.